Loading…

National Vaccination Coverage Among Adolescents Aged 13–17 Years — National Immunization Survey-Teen, United States, 2021

What is already known about this topic? Tetanus, diphtheria, and acellular pertussis vaccine (Tdap), meningococcal conjugate vaccine (MenACWY), and human papillomavirus (HPV) vaccine are routinely recommended for adolescents. What is added by this report? Among adolescents aged 13–17 years in 2021,...

Full description

Saved in:
Bibliographic Details
Published in:MMWR. Morbidity and mortality weekly report 2022-09, Vol.71 (35), p.1101-1108
Main Authors: Pingali, Cassandra, Yankey, David, Elam-Evans, Laurie D, Markowitz, Lauri E, Valier, Madeleine R, Fredua, Benjamin, Crowe, Samuel J, Stokley, Shannon, Singleton, James A
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:What is already known about this topic? Tetanus, diphtheria, and acellular pertussis vaccine (Tdap), meningococcal conjugate vaccine (MenACWY), and human papillomavirus (HPV) vaccine are routinely recommended for adolescents. What is added by this report? Among adolescents aged 13–17 years in 2021, HPV vaccination coverage (≥1 dose and HPV vaccine up to date) increased. Coverage with ≥1-dose Tdap and ≥1-dose MenACWY remained high. Among age-eligible adolescents, MenACWY booster dose coverage increased. Analyses of the potential COVID-19 pandemic effect among adolescents born in 2008 show a concerning decrease in ≥1 MenACWY and ≥1 Tdap dose coverage. What are the implications for public health? As more adolescents who were due for routine vaccinations during the pandemic age into the NIS-Teen sample, the full impact of the pandemic can be assessed. Providers should review vaccination records to ensure that adolescents are current with all recommended vaccinations.
ISSN:0149-2195
1545-861X
DOI:10.15585/mmwr.mm7135a1